Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.76
-1.24 (-11.27%)
At close: Apr 28, 2026, 4:00 PM EDT
9.95
+0.19 (1.95%)
After-hours: Apr 28, 2026, 7:26 PM EDT
Armata Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 4.9 | 5.17 | 4.53 | 5.51 | 4.47 | |
| Revenue Growth (YoY) | -5.22% | 14.24% | -17.77% | 23.11% | 443.62% | |
| Cost of Revenue | 15.72 | 26.03 | 33.77 | 35.02 | 20.02 | |
| Gross Profit | -10.81 | -20.85 | -29.24 | -29.51 | -15.54 | |
| Selling, General & Admin | 20.41 | 21.58 | 11.65 | 7.44 | 8.28 | |
| Operating Expenses | 20.41 | 21.58 | 11.65 | 7.44 | 8.28 | |
| Operating Income | -31.22 | -42.44 | -40.89 | -36.95 | -23.82 | |
| Interest Expense | -16.59 | -10.74 | -2.63 | - | -0.06 | |
| Interest & Investment Income | 0.39 | 0.7 | 0.18 | 0.03 | 0.01 | |
| EBT Excluding Unusual Items | -47.42 | -52.48 | -43.34 | -36.92 | -23.88 | |
| Asset Writedown | -5.41 | - | - | - | - | |
| Other Unusual Items | -120.96 | 33.57 | -25.71 | - | 0.73 | |
| Pretax Income | -173.8 | -18.92 | -69.05 | -36.92 | -23.16 | |
| Net Income | -173.8 | -18.92 | -69.05 | -36.92 | -23.16 | |
| Net Income to Common | -173.8 | -18.92 | -69.05 | -36.92 | -23.16 | |
| Shares Outstanding (Basic) | 36 | 36 | 36 | 34 | 24 | |
| Shares Outstanding (Diluted) | 36 | 59 | 36 | 34 | 24 | |
| Shares Change (YoY) | -38.64% | 63.71% | 5.20% | 42.27% | 46.84% | |
| EPS (Basic) | -4.80 | -0.52 | -1.91 | -1.08 | -0.96 | |
| EPS (Diluted) | -4.80 | -0.89 | -1.91 | -1.08 | -0.96 | |
| Free Cash Flow | -26.31 | -39.43 | -55.57 | -34.69 | -24.88 | |
| Free Cash Flow Per Share | -0.73 | -0.67 | -1.54 | -1.01 | -1.03 | |
| Gross Margin | -220.49% | - | - | - | - | |
| Operating Margin | -636.66% | -820.18% | -902.85% | -670.77% | -532.45% | |
| Profit Margin | -3544.03% | -365.60% | -1524.51% | -670.24% | -517.55% | |
| Free Cash Flow Margin | -536.40% | -762.08% | -1226.91% | -629.85% | -556.08% | |
| EBITDA | -29.69 | -41.11 | -39.92 | -36.05 | -22.65 | |
| D&A For EBITDA | 1.53 | 1.33 | 0.97 | 0.89 | 1.17 | |
| EBIT | -31.22 | -42.44 | -40.89 | -36.95 | -23.82 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.